Table 2 Comparison between ATD-treated patients who could achieve disease remission and patients who could not achieve remission in newly diagnosed Graves’ disease patients
From: Practice patterns and outcomes in the management of Thai patients with Graves’ disease
Patients who achieved remission (N = 316) | Patients who could not achieve remission (N = 712) | p-value | |
|---|---|---|---|
Female (%) | 260 (82.3%) | 583 (81.9%) | 0.930 |
Duration of follow-up (months) | 89.1 + 70.6 | 95.5+ 85.9 | 0.209 |
Age at diagnosis | 38.2 + 11.9 | 35.8 + 12.1 | 0.007 |
- Age < 40 years | 188 (59.5%) | 488 (68.5%) | |
- Age 40–59 years | 111 (35.1%) | 182 (25.6%) | |
- Age ≥ 60 years | 17 (5.4%) | 42 (5.9%) | |
Estimated thyroid size | 0.001 | ||
-Small | 190 (60.1%) | 358 (50.3%) | |
-Medium | 114 (36.1%) | 287 (40.3%) | |
-Huge | 12 (3.8%) | 67 (9.4%) | |
Active smoker | 3 (0.9%) | 18 (2.5%) | 0.149 |
Presence of GO | 24 (7.6%) | 87 (12.2%) | 0.029 |
TSH (mIU/L) | 0.015 + 0.044 | 0.011 + 0.017 | 0.237 |
FT4 (ng/dL) | 4.03 + 1.88 | 4.54 + 1.92 | 0.001 |
T3 (ng/dL) | 340.54 + 145.86 | 408.32 + 167.03 | < 0.001 |